Allogene Therapeutics logo
Allogene Therapeutics ALLO
$ 2.1 2.44%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Allogene Therapeutics Operating Income 2011-2024 | ALLO

Annual Operating Income Allogene Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-328 M -336 M -180 M -258 M -202 M -193 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-180 M -336 M -249 M

Quarterly Operating Income Allogene Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-71.8 M -71.4 M -69.5 M - -63 M -80.5 M -99.1 M - -82.5 M -76.6 M -80 M - -77.7 M -71 M -33.2 M - -68 M -63.2 M -57.7 M -64.6 M -55 M -46 M -36.5 M -33 M -22.2 M -135 M -2.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-2.6 M -135 M -63.5 M